The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Global changes to the ubiquitin system in Huntington's disease
Abstract
Huntington's disease (HD) is a dominantly inherited neurodegenerative disorder caused by expansion of CAG triplet repeats in the huntingtin (HTT) gene (also called HD) and characterized by accumulation of aggregated fragments of polyglutamine-expanded HTT protein in affected neurons. Abnormal enrichment of HD inclusion bodies with ubiquitin, a diagnostic characteristic of HD and many other neurodegenerative disorders including Alzheimer's and Parkinson's diseases, has suggested that dysfunction in ubiquitin metabolism may contribute to the pathogenesis of these diseases. Because modification of proteins with polyubiquitin chains regulates many essential cellular processes including protein degradation, cell cycle, transcription, DNA repair and membrane trafficking, disrupted ubiquitin signalling is likely to have broad consequences for neuronal function and survival. Although ubiquitin-dependent protein degradation is impaired in cell-culture models of HD and of other neurodegenerative diseases, it has not been possible to evaluate the function of the ubiquitin-proteasome system (UPS) in HD patients or in animal models of the disease, and a functional role for UPS impairment in neurodegenerative disease pathogenesis remains controversial. Here we exploit a mass-spectrometry-based method to quantify polyubiquitin chains and demonstrate that the abundance of these chains is a faithful endogenous biomarker of UPS function. Lys 48-linked polyubiquitin chains accumulate early in pathogenesis in brains from the R6/2 transgenic mouse model of HD, from a knock-in model of HD and from human HD patients, establishing that UPS dysfunction is a consistent feature of HD pathology. Lys 63- and Lys 11-linked polyubiquitin chains, which are not typically associated with proteasomal targeting, also accumulate in the R6/2 mouse brain. Thus, HD is linked to global changes in the ubiquitin system to a much greater extent than previously recognized.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ubiquitinand autophagy-based protein clearance systems are highly impaired in Huntington's disease, as evidenced by a striking build-up of ubiquitinated species in patient brain and mouse models”
From Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease (2020) · cites this paper as Bennett et al., 2007
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Self-citationAggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Self-citationImpairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,209
Self-citationPolyubiquitin chains: polymeric protein signals
Pickart, C. M., & Fushman, D. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.09.009 · Cited by 1,075
Neurological abnormalities in a knock-in mouse model of Huntington's disease
Lin, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.2.137 · Cited by 592
Parkin Protects against the Toxicity Associated with Mutant α-Synuclein
Petrucelli, L., O’Farrell, C., Lockhart, P. J., Baptista, M. J., Kehoe, K. J., Vink, L., Choi, P., Wolozin, B. L., Farrer, M. J., Hardy, J., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)01125-x · Cited by 561
Lowe, J., Blanchard, A., Morrell, K., Lennox, G., Reynolds, L., Billett, M., Landon, M., & Mayer, R. J. (1988) · The Journal of Pathology · doi:10.1002/path.1711550105 · Cited by 539
Bennett, E. J., Bence, N., Rajadas, J., & Kopito, R. R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.021 · Cited by 511
Self-citationJana, N. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1049 · Cited by 453
Cited by
Sorted by citations
Huntington's disease: from molecular pathogenesis to clinical treatment
Ross, C. A., & Tabrizi, S. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,816
Systematic and Quantitative Assessment of the Ubiquitin-Modified Proteome
Kim, W., Bennett, E. J., Huttlin, E. L., Guo, A., Li, J., Possemato, A. P., Sowa, M. E., Rad, R., Rush, A. J., Comb, M. J., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.025 · Cited by 1,643
Self-citationThe Biology of Proteostasis in Aging and Disease
Labbadia, J., & Morimoto, R. I. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033955 · Cited by 1,472
Ubiquitination in disease pathogenesis and treatment
Popovic, D., Vucic, D., & Đikić, I. (2014) · Nature Medicine · doi:10.1038/nm.3739 · Cited by 1,443
Xu, P., Duong, D. M., Seyfried, N. T., Cheng, D., Xie, Y., Robert, J., Rush, A. J., Hochstrasser, M., Finley, D. J., & Peng, J. (2009) · Cell · doi:10.1016/j.cell.2009.01.041 · Cited by 1,125
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates
Korolchuk, V. I., Mansilla, A., Menzies, F. M., & Rubinsztein, D. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.021 · Cited by 610
Proteostasis impairment in protein-misfolding and -aggregation diseases
Hipp, M. S., Park, S.-H., & Hartl, F. U. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.05.003 · Cited by 683
Atypical ubiquitylation — the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages
Kulathu, Y., & Komander, D. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3394 · Cited by 619
Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies
Newton, K., Matsumoto, M. L., Wertz, I. E., Kirkpatrick, D. S., Lill, J. R., Tan, J., Dugger, D. L., Gordon, N. C., Sidhu, S. S., Fellouse, F. A., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.039 · Cited by 562
The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development
Bernassola, F., Karin, M., Ciechanover, A., & Melino, G. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.001 · Cited by 541
Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment
Golpich, M., Amini, E., Mohamed, Z., Raymond, A. A., Ibrahim, N. M., & Ahmadiani, A. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12655 · Cited by 555
Haigis, M. C., & Yankner, B. A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.002 · Cited by 488
Mechanisms of neurodegeneration in Huntington’s disease
Gil‐Mohapel, J., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 497
Defining human ERAD networks through an integrative mapping strategy
Christianson, J. C., Olzmann, J. A., Shaler, T. A., Sowa, M. E., Bennett, E. J., Richter, C. M., Tyler, R. E., Greenblatt, E. J., Harper, J. W., & Kopito, R. R. (2011) · Nature Cell Biology · doi:10.1038/ncb2383 · Cited by 482
Self-citationTan, J. M. M., Wong, E. S. P., Kirkpatrick, D. S., Pletniková, O., Ko, H. S., Tay, S.-P., Ho, M. W. L., Troncoso, J. C., Gygi, S. P., Lee, M. K., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm320 · Cited by 457
Endoplasmic reticulum dysfunction in neurological disease
Roussel, B. D., Kruppa, A. J., Miranda, E., Crowther, D. C., Lomas, D. A., & Marciniak, S. J. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70238-7 · Cited by 441
Guerriero, C. J., & Brodsky, J. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00027.2011 · Cited by 429
Protein aggregates in Huntington's disease
Arrasate, M., & Finkbeiner, S. M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.12.013 · Cited by 407
Huntington's disease: underlying molecular mechanisms and emerging concepts
Labbadia, J. P., & Morimoto, R. I. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.05.003 · Cited by 383
Autophagy in Huntington disease and huntingtin in autophagy
Martin, D. D. O., Ladha, S., Ehrnhoefer, D. E., & Hayden, M. R. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.09.003 · Cited by 357
Dantuma, N. P., & Bott, L. C. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00070 · Cited by 354
Polyglutamine neurodegeneration: protein misfolding revisited
Williams, A. J., & Paulson, H. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.004 · Cited by 342
Bedford, L., Hay, D., Devoy, A., Paine, S., Powe, D. G., Seth, R., Gray, T., Topham, I., Fone, K., Rezvani, N., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2218-08.2008 · Cited by 327
“…has been controversial because of conflicting experimental data using inhibitors of the 20S proteolytic core (McNaught et al., 2004; Kordower et al., 2006), but changes in the ubiquitin system are involved in Huntington’s disease neuropathology (Bennett et al., 2007; Wang et al., 2008).”
BackgroundCharizanis, K., Lee, K.-Y., Batra, R., Goodwin, M., Zhang, C., Yuan, Y., Shiue, L., Cline, M., Scotti, M. M., Xia, G., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.05.029 · Cited by 346
Assembly and Function of Heterotypic Ubiquitin Chains in Cell-Cycle and Protein Quality Control
Yau, R. G., Dörner, K., Castellanos, E. R., Haakonsen, D. L., Werner, A. A., Wang, N., Yang, X. W., Martinez-Martín, N., Matsumoto, M. L., Dixit, V. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.040 · Cited by 330
UBXD7 Binds Multiple Ubiquitin Ligases and Implicates p97 in HIF1α Turnover
Alexandru, G., Graumann, J., Smith, G. T., Kolawa, N. J., Fang, R., & Deshaies, R. J. (2008) · Cell · doi:10.1016/j.cell.2008.06.048 · Cited by 311
Impaired ERAD and ER stress are early and specific events in polyglutamine toxicityPreprint
Duennwald, M. L., & Lindquist, S. L. (2008) · Genes & Development · doi:10.1101/gad.1673408 · Cited by 296
Epigenetic principles and mechanisms underlying nervous system functions in health and disease
Mehler, M. F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.10.001 · Cited by 300
Identification of a physiological E2 module for the human anaphase-promoting complex
Williamson, A. P., Wickliffe, K. E., Mellone, B. G., Song, L., Karpen, G. H., & Rapé, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907887106 · Cited by 290
Recent advances in our understanding of neurodegeneration
Jellinger, K. A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0240-y · Cited by 274
Abisambra, J. F., Jinwal, U. K., Blair, L. J., O’Leary, J. C., Li, Q., Brady, S., Wang, L., Guidi, C., Zhang, B., Nordhues, B. A., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5397-12.2013 · Cited by 275
Winborn, B. J., Travis, S. M., Todi, S. V., Scaglione, K. M., Xu, P., Williams, A. J., Cohen, R. E., Peng, J., & Paulson, H. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803692200 · Cited by 261
Lysine 63‐linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome
Saeki, Y., Kudo, T., Sone, T., Kikuchi, Y., Yokosawa, H., Toh‐e, A., & Tanaka, K. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.305 · Cited by 273
Assembly, structure, and function of the 26S proteasome
Bedford, L., Paine, S., Sheppard, P. W., Mayer, R. J., & Roelofs, J. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.03.007 · Cited by 262
Functional Modules of the Proteostasis NetworkPreprint
Jayaraj, G. G., Hipp, M. S., & Hartl, F. U. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033951 · Cited by 254
Kaiser, S. E., Riley, B. E., Shaler, T. A., Trevino, R., Becker, C. H., Schulman, H., & Kopito, R. R. (2011) · Nature Methods · doi:10.1038/nmeth.1649 · Cited by 259
Self-citationUBE2S drives elongation of K11-linked ubiquitin chains by the Anaphase-Promoting Complex
Wu, T., Merbl, Y., Huo, Y., Gallop, J. L., Tzur, A., & Kirschner, M. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912802107 · Cited by 240
Gasset-Rosa, F., Chillón-Marinas, C., Goginashvili, A., Atwal, R. S., Artates, J. W., Tabet, R., Wheeler, V. C., Bang, A. G., Cleveland, D. W., & Lagier‐Tourenne, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.027 · Cited by 233
Dayalu, P., & Albin, R. L. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2014.09.003 · Cited by 243
Huntington's Disease: Can Mice Lead the Way to Treatment?
Crook, Z. R., & Housman, D. E. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.035 · Cited by 236
Froyen, G., Corbett, M. A., Vandewalle, J., Järvelä, I. E., Lawrence, O., Meldrum, C. J., Bauters, M., Govaerts, K., Vandeleur, L., Esch, H. V., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.11.002 · Cited by 233
Clinical Features of Huntington’s Disease
Ghosh, R., & Tabrizi, S. J. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-71779-1_1 · Cited by 207
The ubiquitin proteasome system in neuropathology
Lehman, N. L. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0560-x · Cited by 207
Versatile Roles of K63-Linked Ubiquitin Chains in Trafficking
Erpapazoglou, Z., Walker, O., & Haguenauer‐Tsapis, R. (2014) · Cells · doi:10.3390/cells3041027 · Cited by 218
Signaling Pathways from the Endoplasmic Reticulum and Their Roles in Disease
Kadowaki, H., & Nishitoh, H. (2013) · Genes · doi:10.3390/genes4030306 · Cited by 211
Quantitative Analysis of global Ubiquitination in HeLa Cells by Mass Spectrometry
Meierhofer, D., Wang, X., Huang, L., & Kaiser, P. (2008) · Journal of Proteome Research · doi:10.1021/pr800468j · Cited by 194
Proteasomes Activate Aggresome Disassembly and Clearance by Producing Unanchored Ubiquitin Chains
Hao, R., Nanduri, P., Rao, Y., Panichelli, R. S., Ito, A., Yoshida, M., & Yao, T. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.016 · Cited by 201
Polyglutamine (PolyQ) Diseases: Genetics to Treatments
Fan, H.-C., Ho, L.-I., Chi, C.-S., Chen, S., Peng, G.-S., Chan, T.-M., Lin, S., & Harn, H.-J. (2014) · Cell Transplantation · doi:10.3727/096368914x678454 · Cited by 204
Tydlacka, S., Wang, C.-E., Wang, X., Li, S., & Li, X. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4393-08.2008 · Cited by 186
The Melatonin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity
Wang, X., Sirianni, A. C., Pei, Z., Cormier, K., Smith, K., Jiang, J., Zhou, S., Wang, H., Zhao, R., Yano, H., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3059-11.2011 · Cited by 186
K11-linked ubiquitin chains as novel regulators of cell division
Wickliffe, K. E., Williamson, A. P., Meyer, H., Kelly, A., & Rapé, M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.08.008 · Cited by 196
Dammer, E. B., Na, C. H., Xu, P., Seyfried, N. T., Duong, D. M., Cheng, D., Gearing, M., Rees, H. D., Lah, J. J., Levey, A. I., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149633 · Cited by 194
Olzmann, J. A., & Chin, L. (2008) · Autophagy · doi:10.4161/auto.5172 · Cited by 187
The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies
Bauer, P. O., & Nukina, N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06302.x · Cited by 178
Comparative Proteomic Analysis Identifies a Role for SUMO in Protein Quality Control
Tatham, M. H., Matić, I., Mann, M., & Hay, R. T. (2011) · Science Signaling · doi:10.1126/scisignal.2001484 · Cited by 178
Proteasomal and lysosomal protein degradation and heart disease
Wang, X., & Robbins, J. M. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.006 · Cited by 179
Indirect inhibition of 26S proteasome activity in a cellular model of Huntington’s disease
Hipp, M. S., Patel, C. N., Bersuker, K., Riley, B. E., Kaiser, S. E., Shaler, T. A., Brandeis, M., & Kopito, R. R. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201110093 · Cited by 170
Self-citationImpaired ubiquitin–proteasome system activity in the synapses of Huntington's disease mice
Wang, J., Wang, C.-E., Orr, A. L., Tydlacka, S., Li, S., & Li, X. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200709080 · Cited by 170
The Ubiquitin-Proteasome System in Neurodegeneration
McKinnon, C., & Tabrizi, S. J. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5802 · Cited by 175
Gandhi, J., Antonelli, A. C., Afridi, A., Vatsia, S. K., Joshi, G. S., Romanov, V., Murray, I. V. J., & Khan, S. A. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0035 · Cited by 171
Riley, B. E., Kaiser, S. E., Shaler, T. A., Ng, A., Hara, T., Hipp, M. S., Lage, K., Xavier, R. J., Ryu, K., Taguchi, K., et al. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201005012 · Cited by 165
Self-citationThe Lysine 48 and Lysine 63 Ubiquitin Conjugates Are Processed Differently by the 26 S Proteasome
Jacobson, A. D., Zhang, N., Xu, P., Han, K.-J., Noone, S. M., Peng, J., & Liu, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052928 · Cited by 158
Crapser, J. D., Ochaba, J., Soni, N., Reidling, J. C., Thompson, L. M., & Green, K. N. (2020) · Brain · doi:10.1093/brain/awz363 · Cited by 157
Interaction with Polyglutamine Aggregates Reveals a Q/N-rich Domain in TDP-43
Fuentealba, R. A., Udan-Johns, M., Bell, S., Wegorzewska, I., Shao, J., Diamond, M. I., Weihl, C. C., & Baloh, R. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125039 · Cited by 161
Altered Expression of the Long Noncoding RNA NEAT1 in Huntington’s Disease
Sunwoo, J., Lee, S., Im, W., Lee, M., Byun, J., Jung, K., Park, K., Jung, K., Lee, S. K., Chu, K., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9928-9 · Cited by 154
The elimination of accumulated and aggregated proteins: A role for aggrephagy in neurodegeneration
Yamamoto, A., & Simonsen, A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.015 · Cited by 155
Taurine and central nervous system disorders
Menzie, J., Pan, C., Prentice, H. M., & Wu, J. (2012) · Amino Acids · doi:10.1007/s00726-012-1382-z · Cited by 153
Aldini, G., Vistoli, G., Štefek, M., Chondrogianni, N., Grune, T., Sereikaitė, J., Sadowska‐Bartosz, I., & Bartosz, G. (2013) · Free Radical Research · doi:10.3109/10715762.2013.792926 · Cited by 154
Polyglutamine Diseases: Where does Toxicity Come from? What is Toxicity? Where are We Going?
Takahashi, T., Katada, S., & Onodera, O. (2010) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq005 · Cited by 157
Huntington’s Disease and Mitochondria
Farshbaf, M. J., & Ghaedi, K. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9766-1 · Cited by 153
Improved Quantitative Mass Spectrometry Methods for Characterizing Complex Ubiquitin Signals
Phu, L., Izrael-Tomasevic, A., Matsumoto, M. L., Bustos, D. J., Dynek, J. N., Fedorova, A. V., Bakalarski, C. E., Arnott, D. P., Deshayes, K., Dixit, V. M., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.003756 · Cited by 144
Jia, H., Kast, R. J., Steffan, J. S., & Thomas, E. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds379 · Cited by 146
Mutant huntingtin impairs Ku70-mediated DNA repair
Enokido, Y., Tamura, T., Ito, H., Arumughan, A., Komuro, A., Shiwaku, H., Sone, M., Foulle, R., Sawada, H., Ishiguro, H., et al. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200905138 · Cited by 144
Wei, L., Shen, Y., Xu, F., Hu, F., Harrington, J. K., Targoff, K. L., & Min, W. (2015) · ACS Chemical Biology · doi:10.1021/cb500787b · Cited by 142
Adenosine Receptor Control of Cognition in Normal and Disease
Chen, J. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00012-x · Cited by 142
Disordered Proteinaceous Machines
Fuxreiter, M., Tóth-Petróczy, Á., Kraut, D. A., Matouschek, A. T., Lim, R. Y. H., Xue, B., Kurgan, L., & Uversky, V. N. (2014) · Chemical Reviews · doi:10.1021/cr4007329 · Cited by 138
Parkin-mediated ubiquitin signalling in aggresome formation and autophagy
Chin, L., Olzmann, J. A., & Li, L. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380144 · Cited by 138
Optineurin: A Coordinator of Membrane-Associated Cargo Trafficking and Autophagy
Ryan, T. A., & Tumbarello, D. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01024 · Cited by 140
A Perturbed Ubiquitin Landscape Distinguishes Between Ubiquitin in Trafficking and in Proteolysis
Ziv, I., Matiuhin, Y., Kirkpatrick, D. S., Erpapazoglou, Z., Sébastien Léon, A., Pantazopoulou, M., Kim, W., Gygi, S. P., Haguenauer‐Tsapis, R., Reis, N., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.009753 · Cited by 137
Pathophysiology of Huntingtonʼs disease: from huntingtin functions to potential treatments
Roze, E. F., Saudou, F., & Caboche, J. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328304b692 · Cited by 131
Slowed progression in models of huntington disease by adipose stem cell transplantation
Lee, S., Chu, K., Jung, K., Im, W., Park, J., Lim, H.-C., Won, C. H., Shin, S., Lee, S. K., Kim, M., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21788 · Cited by 128
Wong, H. K., Bauer, P. O., Kurosawa, M., Goswami, A., Washizu, C., Machida, Y., Tosaki, A., Yamada, M., Knöpfel, T., Nakamura, T., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn218 · Cited by 126
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63233-3.00017-8 · Cited by 122
Cellular ubiquitin pool dynamics and homeostasis
Park, C.-W., & Ryu, K. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.9.128 · Cited by 130
Self-citationIron dysregulation in Huntington's disease
Müller, M., & Leavitt, B. R. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12739 · Cited by 123
The Role of Ubiquitin in Autophagy-Dependent Protein Aggregate Processing
Yao, T. (2010) · Genes & Cancer · doi:10.1177/1947601910383277 · Cited by 122
Riguet, N., Mahul-Mellier, A.-L., Maharjan, N., Burtscher, J., Croisier, M., Knott, G., Hastings, J., Patin, A., Reiterer, V., Farhan, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26684-z · Cited by 118
Resolving the Complexity of Ubiquitin Networks
Kliza, K. W., & Husnjak, K. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00021 · Cited by 131
Protein quality control and degradation in cardiomyocytes
Wang, X., Su, H., & Ranek, M. J. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.03.025 · Cited by 120
Suppression of protein aggregation by chaperone modification of high molecular weight complexes
Labbadia, J. P., Novoselov, S. S., Bett, J. S., Weiss, A., Paganetti, P., Bates, G. P., & Cheetham, M. E. (2012) · Brain · doi:10.1093/brain/aws022 · Cited by 117
Self-citationProteotoxic stress and the ubiquitin proteasome system
Kandel, R., Jung, J., & Neal, S. E. (2023) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2023.08.002 · Cited by 124
Tokui, K., Adachi, H., Waza, M., Katsuno, M., Minamiyama, M., Doi, H., Tanaka, K., Hamazaki, J., Murata, S., Tanaka, F., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn419 · Cited by 116
Ubiquitin–proteasome system involvement in Huntington’s disease
Ortega, Z., & Lucas, J. J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00077 · Cited by 117
The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective
Su, H., & Wang, X. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp287 · Cited by 118
Mallory–Denk-bodies: Lessons from keratin-containing hepatic inclusion bodies
Strnad, P., Zatloukal, K., Stumptner, C., Kulaksiz, H., & Denk, H. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.008 · Cited by 115
Chondrogianni, N., Voutetakis, K., Καπετάνου, Μ., Delitsikou, V., Papaevgeniou, N., Sakellari, M., Lefaki, M., Filippopoulou, K., & Gonos, E. S. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.12.003 · Cited by 115
A critical evaluation of the ubiquitin–proteasome system in Parkinson's disease
Cook, C. N., & Petrucelli, L. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.012 · Cited by 119
Protein Misfolding and ER Stress in Huntington's Disease
Shacham, T., Sharma, N., & Lederkremer, G. Z. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00020 · Cited by 115
Emerging regulatory mechanisms in ubiquitin-dependent cell cycle control
Mocciaro, A., & Rapé, M. (2012) · Journal of Cell Science · doi:10.1242/jcs.091199 · Cited by 113
Metadata
- Authors
- Bennett, E. J., Shaler, T. A., Woodman, B., Ryu, K.-Y., Zaitseva, T. S., Becker, C. H., Bates, G. P., Schulman, H., & Kopito, R. R.
- Affiliations
- Stanford University (US)
- King's College London (GB)
- Corresponding author
- Kopito, Ron R.
- ORCID
- Venue
- Nature
- Published
- 2007-08
- Volume
- 448
- Issue
- 7154
- Pages
- 704-708
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2068275936
- Semantic Scholar
- 479d1eb636d3822cf616b0b9cf4afb67080aecda
- Cited by
- 497
- References
- 28
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 10 · 2023: 10 · 2022: 10 · 2021: 17 · 2020: 11 · 2019: 26 · 2018: 20 · 2017: 25 · 2016: 19 · 2015: 25 · 2014: 38 · 2013: 26 · 2012: 38
- FWCI
- 17.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- Huntington's disease, ubiquitin chains, ubiquitin-proteasome system, polyubiquitin, protein aggregation, huntingtin, neurodegeneration, proteasomal degradation, Alzheimer's disease, Parkinson's disease, CAG repeat expansion, brain proteomics
- MeSH terms
- Animals, Brain, Inclusion Bodies, Disease Models, Animal, Humans, Huntington Disease, Lysine, Mice, Transgenic, Ubiquitin, Polyubiquitin, Proteasome Endopeptidase Complex, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review